Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia. / Dewey, Marc; Siebes, Maria; Kachelrieß, Marc; Kofoed, Klaus F.; Maurovich-Horvat, Pál; Nikolaou, Konstantin; Bai, Wenjia; Kofler, Andreas; Manka, Robert; Kozerke, Sebastian; Chiribiri, Amedeo; Schaeffter, Tobias; Michallek, Florian; Bengel, Frank; Nekolla, Stephan; Knaapen, Paul; Lubberink, Mark; Senior, Roxy; Tang, Meng Xing; Piek, Jan J.; van de Hoef, Tim; Martens, Johannes; Schreiber, Laura; on behalf of the Quantitative Cardiac Imaging Study Group.

I: Nature Reviews Cardiology, Bind 17, Nr. 7, 2020, s. 427-450.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Dewey, M, Siebes, M, Kachelrieß, M, Kofoed, KF, Maurovich-Horvat, P, Nikolaou, K, Bai, W, Kofler, A, Manka, R, Kozerke, S, Chiribiri, A, Schaeffter, T, Michallek, F, Bengel, F, Nekolla, S, Knaapen, P, Lubberink, M, Senior, R, Tang, MX, Piek, JJ, van de Hoef, T, Martens, J, Schreiber, L & on behalf of the Quantitative Cardiac Imaging Study Group 2020, 'Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia', Nature Reviews Cardiology, bind 17, nr. 7, s. 427-450. https://doi.org/10.1038/s41569-020-0341-8

APA

Dewey, M., Siebes, M., Kachelrieß, M., Kofoed, K. F., Maurovich-Horvat, P., Nikolaou, K., Bai, W., Kofler, A., Manka, R., Kozerke, S., Chiribiri, A., Schaeffter, T., Michallek, F., Bengel, F., Nekolla, S., Knaapen, P., Lubberink, M., Senior, R., Tang, M. X., ... on behalf of the Quantitative Cardiac Imaging Study Group (2020). Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia. Nature Reviews Cardiology, 17(7), 427-450. https://doi.org/10.1038/s41569-020-0341-8

Vancouver

Dewey M, Siebes M, Kachelrieß M, Kofoed KF, Maurovich-Horvat P, Nikolaou K o.a. Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia. Nature Reviews Cardiology. 2020;17(7):427-450. https://doi.org/10.1038/s41569-020-0341-8

Author

Dewey, Marc ; Siebes, Maria ; Kachelrieß, Marc ; Kofoed, Klaus F. ; Maurovich-Horvat, Pál ; Nikolaou, Konstantin ; Bai, Wenjia ; Kofler, Andreas ; Manka, Robert ; Kozerke, Sebastian ; Chiribiri, Amedeo ; Schaeffter, Tobias ; Michallek, Florian ; Bengel, Frank ; Nekolla, Stephan ; Knaapen, Paul ; Lubberink, Mark ; Senior, Roxy ; Tang, Meng Xing ; Piek, Jan J. ; van de Hoef, Tim ; Martens, Johannes ; Schreiber, Laura ; on behalf of the Quantitative Cardiac Imaging Study Group. / Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia. I: Nature Reviews Cardiology. 2020 ; Bind 17, Nr. 7. s. 427-450.

Bibtex

@article{4ffa167e04734f059f15806a46619d6e,
title = "Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia",
abstract = "Cardiac imaging has a pivotal role in the prevention, diagnosis and treatment of ischaemic heart disease. SPECT is most commonly used for clinical myocardial perfusion imaging, whereas PET is the clinical reference standard for the quantification of myocardial perfusion. MRI does not involve exposure to ionizing radiation, similar to echocardiography, which can be performed at the bedside. CT perfusion imaging is not frequently used but CT offers coronary angiography data, and invasive catheter-based methods can measure coronary flow and pressure. Technical improvements to the quantification of pathophysiological parameters of myocardial ischaemia can be achieved. Clinical consensus recommendations on the appropriateness of each technique were derived following a European quantitative cardiac imaging meeting and using a real-time Delphi process. SPECT using new detectors allows the quantification of myocardial blood flow and is now also suited to patients with a high BMI. PET is well suited to patients with multivessel disease to confirm or exclude balanced ischaemia. MRI allows the evaluation of patients with complex disease who would benefit from imaging of function and fibrosis in addition to perfusion. Echocardiography remains the preferred technique for assessing ischaemia in bedside situations, whereas CT has the greatest value for combined quantification of stenosis and characterization of atherosclerosis in relation to myocardial ischaemia. In patients with a high probability of needing invasive treatment, invasive coronary flow and pressure measurement is well suited to guide treatment decisions. In this Consensus Statement, we summarize the strengths and weaknesses as well as the future technological potential of each imaging modality.",
author = "Marc Dewey and Maria Siebes and Marc Kachelrie{\ss} and Kofoed, {Klaus F.} and P{\'a}l Maurovich-Horvat and Konstantin Nikolaou and Wenjia Bai and Andreas Kofler and Robert Manka and Sebastian Kozerke and Amedeo Chiribiri and Tobias Schaeffter and Florian Michallek and Frank Bengel and Stephan Nekolla and Paul Knaapen and Mark Lubberink and Roxy Senior and Tang, {Meng Xing} and Piek, {Jan J.} and {van de Hoef}, Tim and Johannes Martens and Laura Schreiber and {on behalf of the Quantitative Cardiac Imaging Study Group}",
year = "2020",
doi = "10.1038/s41569-020-0341-8",
language = "English",
volume = "17",
pages = "427--450",
journal = "Nature Reviews Cardiology",
issn = "1759-5002",
publisher = "nature publishing group",
number = "7",

}

RIS

TY - JOUR

T1 - Clinical quantitative cardiac imaging for the assessment of myocardial ischaemia

AU - Dewey, Marc

AU - Siebes, Maria

AU - Kachelrieß, Marc

AU - Kofoed, Klaus F.

AU - Maurovich-Horvat, Pál

AU - Nikolaou, Konstantin

AU - Bai, Wenjia

AU - Kofler, Andreas

AU - Manka, Robert

AU - Kozerke, Sebastian

AU - Chiribiri, Amedeo

AU - Schaeffter, Tobias

AU - Michallek, Florian

AU - Bengel, Frank

AU - Nekolla, Stephan

AU - Knaapen, Paul

AU - Lubberink, Mark

AU - Senior, Roxy

AU - Tang, Meng Xing

AU - Piek, Jan J.

AU - van de Hoef, Tim

AU - Martens, Johannes

AU - Schreiber, Laura

AU - on behalf of the Quantitative Cardiac Imaging Study Group

PY - 2020

Y1 - 2020

N2 - Cardiac imaging has a pivotal role in the prevention, diagnosis and treatment of ischaemic heart disease. SPECT is most commonly used for clinical myocardial perfusion imaging, whereas PET is the clinical reference standard for the quantification of myocardial perfusion. MRI does not involve exposure to ionizing radiation, similar to echocardiography, which can be performed at the bedside. CT perfusion imaging is not frequently used but CT offers coronary angiography data, and invasive catheter-based methods can measure coronary flow and pressure. Technical improvements to the quantification of pathophysiological parameters of myocardial ischaemia can be achieved. Clinical consensus recommendations on the appropriateness of each technique were derived following a European quantitative cardiac imaging meeting and using a real-time Delphi process. SPECT using new detectors allows the quantification of myocardial blood flow and is now also suited to patients with a high BMI. PET is well suited to patients with multivessel disease to confirm or exclude balanced ischaemia. MRI allows the evaluation of patients with complex disease who would benefit from imaging of function and fibrosis in addition to perfusion. Echocardiography remains the preferred technique for assessing ischaemia in bedside situations, whereas CT has the greatest value for combined quantification of stenosis and characterization of atherosclerosis in relation to myocardial ischaemia. In patients with a high probability of needing invasive treatment, invasive coronary flow and pressure measurement is well suited to guide treatment decisions. In this Consensus Statement, we summarize the strengths and weaknesses as well as the future technological potential of each imaging modality.

AB - Cardiac imaging has a pivotal role in the prevention, diagnosis and treatment of ischaemic heart disease. SPECT is most commonly used for clinical myocardial perfusion imaging, whereas PET is the clinical reference standard for the quantification of myocardial perfusion. MRI does not involve exposure to ionizing radiation, similar to echocardiography, which can be performed at the bedside. CT perfusion imaging is not frequently used but CT offers coronary angiography data, and invasive catheter-based methods can measure coronary flow and pressure. Technical improvements to the quantification of pathophysiological parameters of myocardial ischaemia can be achieved. Clinical consensus recommendations on the appropriateness of each technique were derived following a European quantitative cardiac imaging meeting and using a real-time Delphi process. SPECT using new detectors allows the quantification of myocardial blood flow and is now also suited to patients with a high BMI. PET is well suited to patients with multivessel disease to confirm or exclude balanced ischaemia. MRI allows the evaluation of patients with complex disease who would benefit from imaging of function and fibrosis in addition to perfusion. Echocardiography remains the preferred technique for assessing ischaemia in bedside situations, whereas CT has the greatest value for combined quantification of stenosis and characterization of atherosclerosis in relation to myocardial ischaemia. In patients with a high probability of needing invasive treatment, invasive coronary flow and pressure measurement is well suited to guide treatment decisions. In this Consensus Statement, we summarize the strengths and weaknesses as well as the future technological potential of each imaging modality.

U2 - 10.1038/s41569-020-0341-8

DO - 10.1038/s41569-020-0341-8

M3 - Journal article

C2 - 32094693

AN - SCOPUS:85086606165

VL - 17

SP - 427

EP - 450

JO - Nature Reviews Cardiology

JF - Nature Reviews Cardiology

SN - 1759-5002

IS - 7

ER -

ID: 261153858